ImmuneSpec
Timeline
15 events since 2023Board
Capital
Filings
Financial
Establishments
Address
2023202420252026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed PDFabbreviated format · 53 days before the deadline
Power of attorney: Elise Pepermans1 point ▸
- Power of attorney, Elise Pepermans
2025
Registered in the Peppol Directory Reachable for e-invoices through 0208:0797707610
Annual accounts 2024 filed PDFabbreviated format · 64 days before the deadline
Capital increase of €500,06018,184 new shares1 point ▸
- Capital increase, €500,060
- The deed holds 1 more point.
2024
Equity above €2m equity €2.3m ▲22% Equity rises from €1.9m to €2.3m.
Resignation: Geert Baggerman (director)Appointment: Kurt Boonen (director) · Director discharge: Geert Baggerman · General meeting of 17-07-20244 points ▸
- General meeting, 17-07-2024
- Director resignation, Geert Baggerman
- Director discharge, Geert Baggerman
- Director appointment, Kurt Boonen
Annual accounts 2023 filed PDFabbreviated format · 50 days before the deadline
Share issue PDFIssue of 18,184 shares
2 directors appointed, 1 resignationAppointments: Thibault Jonckheere (independent director) and Clean Vision Invest BV · Resignation: VITO NV · Permanent representatives: Robert Fabry and Bart Swaelens · General meeting of 31-01-20248 points ▸
- General meeting, 31-01-2024
- Director appointment, Thibault Jonckheere (independent director)
- Director resignation, VITO NV
- Director discharge, VITO NV
- Director discharge, Robert Fabry (representative)
- Permanent representative, Robert Fabry
- Director appointment, Clean Vision Invest BV
- Permanent representative, Bart Swaelens
- The deed holds 1 more point.
2023
Registered office moved from Hove to NielNew registered office: Galileilaan 18 bus 006, 2845 Niel (België) · Previous registered office: Mortselsesteenweg 136, 2540 Hove (België) · Board meeting of 30-03-20232 points ▸
- Board meeting, 30-03-2023
- Registered-office move, Galileilaan 18 bus 006, 2845 Niel (België)
1 director appointed, 1 resignationResignation: HERAN HealthTech Fund I CommV · Permanent representatives: Katleen Vandersmissen and Geoffrey D'hondt · Appointment: HERAN Partners BV · General meeting of 13-04-20236 points ▸
- General meeting, 13-04-2023
- Director resignation, HERAN HealthTech Fund I CommV
- Permanent representative, Katleen Vandersmissen
- Director discharge, HERAN HealthTech Fund I CommV
- Director appointment, HERAN Partners BV
- Permanent representative, Geoffrey D'hondt
4 directors appointed, 3 resignationsCapital from €15,000 to €1,115,000, 40,000 new shares · Capital from €1,115,000 to €2,314,990, 43,636 new shares · Resignations: PEPERMANS, Elise; BOONEN, Kurt and BAGGERMAN, Geert Luc Elisabeth11 points ▸
- Capital increase, €1,100,000
- Capital increase, €1,199,990
- Director resignation, PEPERMANS, Elise
- Director resignation, BOONEN, Kurt
- Director resignation, BAGGERMAN, Geert Luc Elisabeth
- Director appointment, BAGGERMAN, Geert Luc Elisabeth
- Director appointment, VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK
- Director appointment, HERAN HEALTHTECH FUND I
- Director appointment, PEPERMANS, Elise
- Permanent representative, FABRY, Robert Leopold Alain Marie
- Permanent representative, VANDERSMISSEN, Katleen
- The deed holds 6 more points.
IncorporationFounding capital of €15,000 · Founders: PEPERMANS, Elise Godelieve Louis; BOONEN, Kurt; BAGGERMAN, Geert Luc Elisabeth · Appointments: PEPERMANS, Elise Godelieve Louis; BOONEN, Kurt and BAGGERMAN, Geert Luc Elisabeth · published on 31-01-20238 points ▸
- Director appointment, PEPERMANS, Elise Godelieve Louis (director (not named in the articles))
- Director appointment, BOONEN, Kurt (director (not named in the articles))
- Director appointment, BAGGERMAN, Geert Luc Elisabeth (director (not named in the articles))
- Registered office clause, Mortselsesteenweg 136, 2540 Hove
- Founder, PEPERMANS, Elise Godelieve Louis
- Founder, BOONEN, Kurt
- Founder, BAGGERMAN, Geert Luc Elisabeth
- Founding capital, €15,000
- The deed holds 2 more points.
First establishment Galileilaan 18, Niel
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
On 27 January 2023, ImmuneSpec was incorporated as a private limited company by three natural persons, with a starting capital of €15,000.12 In 2023 the registered office moved to Niel.3 The capital was increased 2 times between 2023 and 2025.45 Of the 3 current board members, Heran Partners has served longest, since 2023.6 Total assets went from €3.2m in 2023 to €3.5m in 2025 and headcount from 1.7 to 5.7 full-time equivalents.7